Keywords: gsk, drops, japanese, partner, zantac, uk, drug

GSK drops Japanese partner for Zantac

Article | 28 April 2008

Print This

UK drug giant GlaxoSmithKline has terminated its co-marketing agreement for the now off patent antiulcer drug Zantac (ranitidine) in Japan ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in